Human adenovirus-36 seropositivity and obesity among Midwestern US adolescents

Objective Human adenovirus-36 (Ad-36) infection has been implicated as a risk factor for obesity. This study aims to measure Ad-36 antibody prevalence among obese and healthy-weight Midwestern US adolescents. Methods Obese and healthy-weight subjects 10-18 years of age attending an adolescent clinic...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of adolescent medicine and health Vol. 32; no. 3
Main Authors Tosh, Aneesh K., Wasserman, Mollie G., McLeay II, Matthew T., Tepe, Sara K.
Format Journal Article
LanguageEnglish
Published Germany De Gruyter 23.11.2017
Walter de Gruyter GmbH
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective Human adenovirus-36 (Ad-36) infection has been implicated as a risk factor for obesity. This study aims to measure Ad-36 antibody prevalence among obese and healthy-weight Midwestern US adolescents. Methods Obese and healthy-weight subjects 10-18 years of age attending an adolescent clinic in Missouri, USA, were tested for Ad-36 antibodies via ELISA assay. All subjects were measured for height and weight to determine body mass index (BMI). χ2 analysis was used to compare Ad-36 antibody prevalence between the two groups. Results Ad-36 antibodies were tested on 41 obese and 37 control subjects. The subjects' mean age at the time of sample collection was 15.6 years (SD 2.0). Ad-36 antibody prevalence was 43.9% among the obese group and 21.6% among the control group (p = 0.038). Discussion The findings show that statistically more obese Missouri adolescents test positive for Ad-36 antibodies than their healthy-weight peers, consistent with previous findings suggesting a correlation between Ad-36 infection and obesity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0334-0139
2191-0278
DOI:10.1515/ijamh-2017-0126